← back to ai-native-discovery-engine
Financial analysis · adoption-ready estimate
DiscoveryOS - Autonomous Research Platform
If an entrepreneur "adopted" this product today, here's the realistic math.
Fermi summary
If you close 12 biotech research teams at $28k/year, that's $336k ARR - but with a 7% shot at getting there inside 12 months and $148k to invest, expected year-one take-home is -$132k. This needs deep pockets, domain credibility, and patience.
Market size (TAM)
$320.0M
~10,000 addressable orgs globally (pharma, biotech, industrial R&D, large research universities) × $32k avg annual contract for AI research tooling
Year-1 ARR range
$75k - $1.1M
midpoint $340k
Investment to production
$148k
Dev: $72k for AI pipeline hardening, data connectors (PubMed, patents, internal corpora), auth/billing. Sales: $42k for 2-3 biotech conferen
Probability of success
7%
P(reaching mid case in 12 months)
Expected take-home Y1
$-132000
probability-weighted, after investment
Go-to-market motion
Outbound to VPs of Research and heads of computational biology at 200-800 person biotech companies → free 30-day proof-of-concept on a real research question → $25k-$50k annual close after 4-9 month procurement cycle.
Key risks
- AI hallucination in scientific claims is uniquely lethal here - one high-profile wrong 'discovery' that a team acts on destroys reputation in a small, gossipy industry with no recovery path
- Pharma/biotech procurement averages 6-12 months from demo to signed contract, meaning initial investment is nearly fully burned before first ARR arrives
- Compute costs per 'autonomous discovery run' are unbounded and hard to price - a customer with a large dataset could make a $30k contract unprofitable in a single sprint
Generated by the Wishdeal Factory financial-analysis agent. Numbers are honest Fermi estimates, not guarantees. Real outcomes depend on the operator. The studio is bullish on the engineering quality, agnostic on the business outcome.